DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use
May 08, 2021, at 11:57 pm
New Delhi/IBNS: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.
Indian scientists working on anti-COVID-19 drugs using garlic essential oil
Apr 23, 2020, at 02:51 pm
New Delhi/IBNS: Department of Biotechnology’s Center of Innovative and Applied Bioprocessing (DBT-CIAB) at Mohali, has planned a bouquet of research projects aimed at generating products that could be used for prevention, diagnosis or cure of for the deadly COVID 19 infection that is currently sweeping over the entire world.